Market Indices
Sector Heatmap
SBIO — ALPS Medical Breakthroughs ETF
NYSE ArcaALPS Medical Breakthroughs ETF
- O
- 56.28
- H
- 56.28
- L
- 53.89
- V
- 93.16K
SBIO — Latest News & Headlines
20 StoriesNuvation Bio Inc. (NUVB) stock price, news, quote and history - Yahoo Finance UK
Nuvation Bio Inc. (NUVB) stock price, news, quote and history Yahoo Finance UK
Why is Q32 Bio stock sliding today? - Investing.com
Why is Q32 Bio stock sliding today? Investing.com
Why (SBIO) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Why (SBIO) Price Action Is Critical for Tactical Trading Stock Traders Daily
Palisade Bio Stock Price Forecast. Should You Buy PALI? - StockInvest.us
Palisade Bio Stock Price Forecast. Should You Buy PALI? StockInvest.us
SBIO: Promising Pipelines, Insufficient Return Potential - Seeking Alpha
SBIO: Promising Pipelines, Insufficient Return Potential Seeking Alpha
NUVB Stock Is Soaring Today — Why RBC Sees $3B Opportunity In Nuvation Bio's Brain Cancer Drug - Stocktwits
NUVB Stock Is Soaring Today — Why RBC Sees $3B Opportunity In Nuvation Bio's Brain Cancer Drug Stocktwits
Generation Bio stock deal closes at USD 4.2913 per share - AD HOC NEWS
Generation Bio stock deal closes at USD 4.2913 per share AD HOC NEWS
Oppenheimer reiterates Q32 Bio stock rating on durable trial data - Investing.com
Oppenheimer reiterates Q32 Bio stock rating on durable trial data Investing.com
Gritstone bio stock faces a USD 6 million settlement - AD HOC NEWS
Gritstone bio stock faces a USD 6 million settlement AD HOC NEWS
Zura Bio stock heads into Piper Sandler meeting with losses widening - AD HOC NEWS
Zura Bio stock heads into Piper Sandler meeting with losses widening AD HOC NEWS
KALA BIO stock targets telehealth expansion with a USD 15.00 million LOI - AD HOC NEWS
KALA BIO stock targets telehealth expansion with a USD 15.00 million LOI AD HOC NEWS
Gossamer Bio stock heads toward October 27 vote after Nasdaq win - AD HOC NEWS
Gossamer Bio stock heads toward October 27 vote after Nasdaq win AD HOC NEWS
Gossamer Bio stock falls 5.99 percent after FDA filing - AD HOC NEWS
Gossamer Bio stock falls 5.99 percent after FDA filing AD HOC NEWS
Guggenheim reiterates Buy rating for Zura Bio stock - AD HOC NEWS
Guggenheim reiterates Buy rating for Zura Bio stock AD HOC NEWS
Generation Bio stock was delisted after a USD 4.2913 merger - AD HOC NEWS
Generation Bio stock was delisted after a USD 4.2913 merger AD HOC NEWS
INmune Bio stock holds at USD 1.93 as filing plans advance - AD HOC NEWS
INmune Bio stock holds at USD 1.93 as filing plans advance AD HOC NEWS
Gossamer Bio stock gained 1.22 percent on October 6 after FDA filing supporter ????? no - AD HOC NEWS
Gossamer Bio stock gained 1.22 percent on October 6 after FDA filing supporter ????? no AD HOC NEWS
Annovis Bio stock reports 862 Phase 3 enrollments - AD HOC NEWS
Annovis Bio stock reports 862 Phase 3 enrollments AD HOC NEWS
Kyntra Bio stock falls 3.02 percent as board changes - AD HOC NEWS
Kyntra Bio stock falls 3.02 percent as board changes AD HOC NEWS
INmune Bio stock falls 3.61 percent as October catalysts approach - AD HOC NEWS
INmune Bio stock falls 3.61 percent as October catalysts approach AD HOC NEWS